Literature DB >> 19205918

Cyclophosphamide induces premature senescence in normal human fibroblasts by activating MAP kinases.

Arivazhagan Palaniyappan1.   

Abstract

Cellular senescence is induced by diverse mechanisms and is in turn mediated by multiple biochemical pathways. We found that cyclophosphamide sensitively inhibits the growth of normal human fibroblasts. Those growth arrested fibroblasts showed morphology similar to that of normally senesced cells and strongly expressed senescence-associated β-galactosidase. They also showed up regulation of senescence-associated genes and eventually lost their division potential. In addition, enhanced phosphorylation of MAP kinases was found in growth arrested cells, very similar to normally senesced cells. Collectively, these results suggest that cyclophosphamide uses signaling pathways similar to those that are active in replicative senescence, thereby leading to premature senescence.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19205918     DOI: 10.1007/s10522-009-9215-5

Source DB:  PubMed          Journal:  Biogerontology        ISSN: 1389-5729            Impact factor:   4.277


  7 in total

Review 1.  Convergence of therapy-induced senescence (TIS) and EMT in multistep carcinogenesis: current opinions and emerging perspectives.

Authors:  Mir Mohd Faheem; Nathan D Seligson; Syed Mudabir Ahmad; Reyaz Ur Rasool; Sumit G Gandhi; Madhulika Bhagat; Anindya Goswami
Journal:  Cell Death Discov       Date:  2020-06-15

2.  Senotherapy Protects against Cisplatin-Induced Ovarian Injury by Removing Senescent Cells and Alleviating DNA Damage.

Authors:  Dingfu Du; Xianan Tang; Yufeng Li; Yueyue Gao; Runhua Chen; Qian Chen; Jingyi Wen; Tong Wu; Yan Zhang; Huan Lu; Jinjin Zhang; Shixuan Wang
Journal:  Oxid Med Cell Longev       Date:  2022-06-03       Impact factor: 7.310

Review 3.  Molecular mechanisms and cardiovascular implications of cancer therapy-induced senescence.

Authors:  Ibrahim Y Abdelgawad; Karim T Sadak; Diana W Lone; Mohamed S Dabour; Laura J Niedernhofer; Beshay N Zordoky
Journal:  Pharmacol Ther       Date:  2020-12-01       Impact factor: 12.310

4.  Efficient induction of apoptosis by proteasome inhibitor: bortezomib in the human breast cancer cell line MDA-MB-231.

Authors:  Rafał Krętowski; Małgorzata Borzym-Kluczyk; Marzanna Cechowska-Pasko
Journal:  Mol Cell Biochem       Date:  2014-01-03       Impact factor: 3.396

5.  Hypoxia enhances the senescence effect of bortezomib--the proteasome inhibitor--on human skin fibroblasts.

Authors:  Rafał Krętowski; Małgorzata Borzym-Kluczyk; Marzanna Cechowska-Pasko
Journal:  Biomed Res Int       Date:  2014-01-29       Impact factor: 3.411

Review 6.  Convergence of therapy-induced senescence (TIS) and EMT in multistep carcinogenesis: current opinions and emerging perspectives.

Authors:  Mir Mohd Faheem; Nathan D Seligson; Syed Mudabir Ahmad; Reyaz Ur Rasool; Sumit G Gandhi; Madhulika Bhagat; Anindya Goswami
Journal:  Cell Death Discov       Date:  2020-06-15

Review 7.  Small molecule compounds that induce cellular senescence.

Authors:  Nadezhda V Petrova; Artem K Velichko; Sergey V Razin; Omar L Kantidze
Journal:  Aging Cell       Date:  2016-09-14       Impact factor: 9.304

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.